TOI News and Press, The Oncology Institute Inc. From 06/27/22

Cancer-care provider The Oncology Institute (NASDAQ:TOI) on Monday said it had signed an expanded partnership with U.S.-drug distributor McKesson (NYSE:MCK) for drug distribution and clinical technology. The agreement is for multiple years and is expected to help streamline TOI's pharmaceutic...

CERRITOS, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, announced today the signing of an expanded partnership agreement with McK...

CERRITOS, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate in the “Value-Based Care for Medica...

CERRITOS, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000 Ò and Russell 3000 Ò Indexes after the 2022 Russell ...

AUSTIN, Texas, June 02, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, is expanding its footprint into Austin, Texas with the opening of two new specialty cancer clinics. The first clinic opened to re...

CERRITOS, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Brad Hively, Chief Executive Officer, will participate at the following investor conferences: UBS Heal...

The Oncology Institute, Inc. (TOI) Q1 2022 Earnings Conference Call May 11, 2022 5:00 PM ET Company Participants Mihir Shah – Chief Financial Officer Brad Hively – Chief Executive Officer Conference Call Participants Brian Tanquilut – Jefferies Gary Taylor – Cowen ...

The Oncology Institute press release (NASDAQ:TOI): Q1 GAAP EPS of $0.21. Revenue of $55.16M (+13.5% Y/Y). 2022 Guidance: Revenue of $270 to $310 million vs consensus of , representing approximately 33% to 53% growth over 2021 revenue; Adj EBITDA of -$20M to -$25M For further details see: ...

CERRITOS, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today reported financial results for its first quarter ended March 31, 2022. "We are pleased with the resu...

The shares of The Oncology Institute (NASDAQ:TOI) have approached the highest level since early January after the Cerritos, California-based oncology service provider announced the acquisition of Women’s Cancer Care, a clinical practice run by Christopher R. Perkins M.D. and Lisa Ge, M...